Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real‐Life Populations

Potential conflict of interest: Nothing to report. See Article on Page 1521 Nonalcoholic fatty liver disease (NAFLD) has become extremely common, now affecting 25% of the worldwide population.1 All physicians, regardless of their specialty, are seeing patients with NAFLD in their daily clinical practice, and all are challenged by the identification of the small subgroup having an advanced form of the disease. As with the other causes of chronic...